Before the surprise election of Donald Trump to be president, creating new incentives for antibiotic development had been seen as one area of potential bipartisan agreement on health policy. That’s still true, but any solutions that are created will have a much more Republican favor.
At a forum on economic incentives for antimicrobials held Nov. 9, the day after the election, Gregory Daniel, deputy director...





